Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma. This evidence concerns the gene FOLH1 and pancreatic ductal adenocarcinoma.